BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37024846)

  • 21. HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.
    Kashofer K; Winter E; Halbwedl I; Thueringer A; Kreiner M; Sauer S; Regauer S
    Mod Pathol; 2017 Jul; 30(7):1013-1020. PubMed ID: 28387325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.
    Zhang D; Zhang W; Liu W; Mao Y; Fu Z; Liu J; Huang W; Zhang Z; An D; Li B
    Radiother Oncol; 2017 Jul; 124(1):155-160. PubMed ID: 28647401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
    Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
    J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53 mutations in head and neck cancer.
    Nathan CA; Khandelwal AR; Wolf GT; Rodrigo JP; Mäkitie AA; Saba NF; Forastiere AA; Bradford CR; Ferlito A
    Mol Carcinog; 2022 Apr; 61(4):385-391. PubMed ID: 35218075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting survival in head and neck squamous cell carcinoma from TP53 mutation.
    Masica DL; Li S; Douville C; Manola J; Ferris RL; Burtness B; Forastiere AA; Koch WM; Chung CH; Karchin R
    Hum Genet; 2015 May; 134(5):497-507. PubMed ID: 25108461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
    Loeb KR; Asgari MM; Hawes SE; Feng Q; Stern JE; Jiang M; Argenyi ZB; de Villiers EM; Kiviat NB
    PLoS One; 2012; 7(4):e34422. PubMed ID: 22545084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Data of P53 R282 Gene Mutation with Human Papillomaviruses (HPV)-Associated Oral Squamous Cell Carcinoma (OSCC).
    Ekalaksananan T; Wongjampa W; Phusingha P; Chuerduangphui J; Vatanasapt P; Promthet S; Patarapadungkit N; Pientong C
    Pathol Oncol Res; 2020 Apr; 26(2):1191-1199. PubMed ID: 31197568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Genomic Landscape of Vulvar Squamous Cell Carcinoma.
    Corey L; Wallbillich JJ; Wu S; Farrell A; Hodges K; Xiu J; Nabhan C; Guastella A; Kheil M; Gogoi R; Winer I; Bandyopadhyay S; Huang M; Jones N; Wilhite A; Karnezis A; Thaker P; Herzog TJ; Oberley M; Korn WM; Vezina A; Morris R; Ali-Fehmi R
    Int J Gynecol Pathol; 2023 Sep; 42(5):515-522. PubMed ID: 37131274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.
    Wichmann G; Rosolowski M; Krohn K; Kreuz M; Boehm A; Reiche A; Scharrer U; Halama D; Bertolini J; Bauer U; Holzinger D; Pawlita M; Hess J; Engel C; Hasenclever D; Scholz M; Ahnert P; Kirsten H; Hemprich A; Wittekind C; Herbarth O; Horn F; Dietz A; Loeffler M;
    Int J Cancer; 2015 Dec; 137(12):2846-57. PubMed ID: 26095926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus infection and p53 mutation in esophageal squamous cell carcinoma and its impact on treatment outcome.
    Singh T; Shirazi N; Bansal S; Gupta M; Saini S; Ahmad M
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S150-S155. PubMed ID: 33380670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma.
    Portugal LG; Goldenberg JD; Wenig BL; Ferrer KT; Nodzenski E; Sabnani JB; Javier C; Weichselbaum RR; Vokes EE
    Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1230-4. PubMed ID: 9366703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.
    Deneka AY; Baca Y; Serebriiskii IG; Nicolas E; Parker MI; Nguyen TT; Xiu J; Korn WM; Demeure MJ; Wise-Draper T; Sukari A; Burtness B; Golemis EA
    Clin Cancer Res; 2022 May; 28(9):1925-1937. PubMed ID: 35491653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
    Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
    Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prognostic and Predictive Effects of Human Papillomavirus Status in Hypopharyngeal Carcinoma: Population-Based Study.
    Yang SP; Lin XY; Hu M; Cai CF
    JMIR Public Health Surveill; 2022 Dec; 8(12):e40185. PubMed ID: 36525304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of TP53 mutations in vulvar carcinomas.
    Choschzick M; Hantaredja W; Tennstedt P; Gieseking F; Wölber L; Simon R
    Int J Gynecol Pathol; 2011 Sep; 30(5):497-504. PubMed ID: 21804386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
    Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
    Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples.
    de Carvalho AC; Melendez ME; da Silva Sabato C; Palmero EI; Arantes LMRB; Neto CS; Carvalho AL
    Pathol Oncol Res; 2019 Jul; 25(3):1047-1058. PubMed ID: 30099696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.